Sign in
4

Changes in Ownership

Protagenic Therapeutics, Inc.new Filed Acc 0001144204-10-036315

Options or other derivatives

  • Chief Financial Officer acquired 250,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Plotts Thomas · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2010-06-30 Grant or award : show line 1 in the form Options to Purchase Common Stock +250,000 250,000 D
Loading xslF345X03/v189779_ex.xml…